INHIBITION OF CISPLATIN-INDUCED VOMITING BY SELECTIVE 5-HYDROXYTRYPTAMINE M-RECEPTOR ANTAGONISM

被引：325

作者：

MINER, WD ^{[1
]}

SANGER, GJ ^{[1
]}

机构：

[1] BEECHAM PHARMACEUT,DIV RES,COLDHARBOUR RD,HARLOW CM19 5AD,ESSEX,ENGLAND

来源：

BRITISH JOURNAL OF PHARMACOLOGY | 1986年 / 88卷 / 03期

关键词：

D O I：

10.1111/j.1476-5381.1986.tb10228.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：497 / 499

页数：3

共 11 条

[1]

FLORCZYK AP, 1982, CANCER TREAT REP, V66, P187

[2] MDL-72222 - A POTENT AND HIGHLY SELECTIVE ANTAGONIST AT NEURONAL 5-HYDROXYTRYPTAMINE RECEPTORS [J].

FOZARD, JR .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1984, 326 (01) :36-44

[3] NEURONAL 5-HT RECEPTORS IN THE PERIPHERY [J].

FOZARD, JR .

NEUROPHARMACOLOGY, 1984, 23 :1473-1486

[4] ANTI-EMETIC EFFICACY OF HIGH-DOSE METOCLOPRAMIDE - RANDOMIZED TRIALS WITH PLACEBO AND PROCHLORPERAZINE IN PATIENTS WITH CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING [J].

GRALLA, RJ ;

ITRI, LM ;

PISKO, SE ;

SQUILLANTE, AE ;

KELSEN, DP ;

BRAUN, DW ;

BORDIN, LA ;

BRAUN, TJ ;

YOUNG, CW .

NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (16) :905-909

[5] METOCLOPRAMIDE - AN UPDATED REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL USE [J].

HARRINGTON, RA ;

HAMILTON, CW ;

BROGDEN, RN ;

LINKEWICH, JA ;

ROMANKIEWICZ, JA ;

HEEL, RC .

DRUGS, 1983, 25 (05) :451-494

[6]

HARRIS AL, 1982, LANCET, V1, P714

[7]

LESLIE RA, 1984, FED PROC, V43, P2941

[8]

MCCARTHY LE, 1984, CANCER TREAT REP, V68, P401

[9]

PERROT J, 1982, TREATMENT CANCER CHE, P195

[10]

PICKEL VM, 1984, FED PROC, V43, P2949

← 1 2 →